OncoSec Medical
ONCSQ · OTC
$0.00+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
ONCSQ profitability and balance sheet ratios
Debt to assets 25.8% in Jan 2023.
| Period | Debt to assets |
|---|---|
| Jul 2022 | 4.3% |
| Oct 2022 | 4.6% |
| Jan 2023 | 25.8% |
Income statement
No financial statements are reported for OncoSec Medical.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Jul 2022 | Oct 2022 | Jan 2023 |
|---|---|---|---|
| Total assets | $21.9M | $14.4M | $8.9M |
| Total liabilities | $15.8M | $15.4M | $14.4M |
| Shareholder equity | $6.1M | −$1.0M | −$5.5M |
| Cash and short-term investments | $12.3M | $5.7M | $3.7M |
| Total debt | $0.9M | $0.7M | $2.3M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.